SAFLF
Price
$1.60
Change
+$0.10 (+6.67%)
Updated
Sep 2 closing price
Capitalization
710.16M
XAIR
Price
$2.19
Change
+$0.02 (+0.92%)
Updated
Sep 5, 02:36 PM (EDT)
Capitalization
11.34M
73 days until earnings call
Interact to see
Advertisement

SAFLF vs XAIR

Header iconSAFLF vs XAIR Comparison
Open Charts SAFLF vs XAIRBanner chart's image
Safilo Group Spa
Price$1.60
Change+$0.10 (+6.67%)
Volume$100
Capitalization710.16M
Beyond Air
Price$2.19
Change+$0.02 (+0.92%)
Volume$100
Capitalization11.34M
SAFLF vs XAIR Comparison Chart in %
Loading...
SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XAIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SAFLF vs. XAIR commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SAFLF is a Buy and XAIR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (SAFLF: $1.60 vs. XAIR: $2.17)
Brand notoriety: SAFLF and XAIR are both not notable
SAFLF represents the Pharmaceuticals: Other, while XAIR is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: SAFLF: 0% vs. XAIR: 50%
Market capitalization -- SAFLF: $710.16M vs. XAIR: $11.34M
SAFLF [@Pharmaceuticals: Other] is valued at $710.16M. XAIR’s [@Medical/Nursing Services] market capitalization is $11.34M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.15B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SAFLF’s FA Score shows that 0 FA rating(s) are green whileXAIR’s FA Score has 1 green FA rating(s).

  • SAFLF’s FA Score: 0 green, 5 red.
  • XAIR’s FA Score: 1 green, 4 red.
According to our system of comparison, SAFLF is a better buy in the long-term than XAIR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SAFLF’s TA Score shows that 2 TA indicator(s) are bullish while XAIR’s TA Score has 6 bullish TA indicator(s).

  • SAFLF’s TA Score: 2 bullish, 3 bearish.
  • XAIR’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, XAIR is a better buy in the short-term than SAFLF.

Price Growth

SAFLF (@Pharmaceuticals: Other) experienced а +6.67% price change this week, while XAIR (@Medical/Nursing Services) price change was -0.46% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.57%. For the same industry, the average monthly price growth was +6.79%, and the average quarterly price growth was +18.37%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.15%. For the same industry, the average monthly price growth was +4.26%, and the average quarterly price growth was +24.88%.

Reported Earning Dates

XAIR is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.57% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.15% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAFLF($710M) has a higher market cap than XAIR($11.3M). SAFLF YTD gains are higher at: 63.215 vs. XAIR (-69.735). SAFLF has higher annual earnings (EBITDA): 107M vs. XAIR (-37.23M). SAFLF has more cash in the bank: 72.6M vs. XAIR (6.46M). XAIR has less debt than SAFLF: XAIR (13.7M) vs SAFLF (115M). SAFLF has higher revenues than XAIR: SAFLF (999M) vs XAIR (4.78M).
SAFLFXAIRSAFLF / XAIR
Capitalization710M11.3M6,283%
EBITDA107M-37.23M-287%
Gain YTD63.215-69.735-91%
P/E Ratio12.28N/A-
Revenue999M4.78M20,891%
Total Cash72.6M6.46M1,123%
Total Debt115M13.7M839%
FUNDAMENTALS RATINGS
SAFLF vs XAIR: Fundamental Ratings
SAFLF
XAIR
OUTLOOK RATING
1..100
5063
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
28
Undervalued
PROFIT vs RISK RATING
1..100
72100
SMR RATING
1..100
70100
PRICE GROWTH RATING
1..100
3694
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
3285

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XAIR's Valuation (28) in the null industry is somewhat better than the same rating for SAFLF (64). This means that XAIR’s stock grew somewhat faster than SAFLF’s over the last 12 months.

SAFLF's Profit vs Risk Rating (72) in the null industry is in the same range as XAIR (100). This means that SAFLF’s stock grew similarly to XAIR’s over the last 12 months.

SAFLF's SMR Rating (70) in the null industry is in the same range as XAIR (100). This means that SAFLF’s stock grew similarly to XAIR’s over the last 12 months.

SAFLF's Price Growth Rating (36) in the null industry is somewhat better than the same rating for XAIR (94). This means that SAFLF’s stock grew somewhat faster than XAIR’s over the last 12 months.

SAFLF's P/E Growth Rating (100) in the null industry is in the same range as XAIR (100). This means that SAFLF’s stock grew similarly to XAIR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SAFLFXAIR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
42%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
27%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
23%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 16 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
27%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XAIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WSBC32.990.34
+1.04%
WesBanco
SBFG22.030.12
+0.55%
SB Financial Group
GCMG12.720.05
+0.39%
GCM Grosvenor
ES63.420.12
+0.19%
Eversource Energy
EPIX0.23N/A
-2.07%
ESSA Pharma

SAFLF and

Correlation & Price change

A.I.dvisor tells us that SAFLF and ICCM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SAFLF and ICCM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAFLF
1D Price
Change %
SAFLF100%
N/A
ICCM - SAFLF
28%
Poorly correlated
+0.95%
MDXH - SAFLF
28%
Poorly correlated
-1.67%
XAIR - SAFLF
25%
Poorly correlated
-6.06%
GRRMF - SAFLF
24%
Poorly correlated
N/A
AMBBY - SAFLF
24%
Poorly correlated
-1.93%
More

XAIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XAIR has been loosely correlated with CZMWY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if XAIR jumps, then CZMWY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XAIR
1D Price
Change %
XAIR100%
-6.06%
CZMWY - XAIR
38%
Loosely correlated
-1.32%
SHWGY - XAIR
36%
Loosely correlated
N/A
RBOT - XAIR
32%
Poorly correlated
-2.23%
CZMWF - XAIR
31%
Poorly correlated
N/A
IRME - XAIR
27%
Poorly correlated
N/A
More